The Traderszone Network

A day after at least one report suggested Greece will “probably” make a bid to join the BRICS bank, marking the dreaded ‘Russian pivot’ and representing the last bit of leverage Athens has left now that regional and local elections in Spain have made it clear that ideologically similar parties may soon sweep to power in other periphery countries much as Syriza did in Greece five months ago, it appears the country and its creditors will miss the Sunday deadline they set for

read more

You won’t believe the ingredients Watson throws together for a tasty meal. Here’s why the supercomputer’s cooking abilities are vitally important for the health care industry.

The cruise line industry is a great way to coast along for gains, as long as you don’t mind the choppy waters.

Why would VW Group build a 600-horsepower Lamborghini SUV? The reason is pretty simple.

Athens and its euro zone and International Monetary Fund (IMF) creditors have been locked in talks for months without luck on a deal. Pressure to strike one has intensified as Athens faces a debt payment on June 5 as well as the expiration of its bailout program on June 30. The government said this week it was looking for a deal by Sunday, but sources close to the talks at the so-called Brussels Group of EU/IMF creditors said that was unlikely.

AbbVie and Gilead are often compared because of their competing hepatitis C drugs. These two biopharmas nevertheless have fundamentally different core areas of expertise and approaches to drug development. And these differences give AbbVie a better long-term outlook than Gilead.

You have to be wary of making math mistakes with long-term inflation.